natgillin/translations-raw huggingface dataset:
1). ) lahko pomaga pri spoprijemanju s to težavo v Evropi; poziva Komisijo in države članice, naj dajo največjo prednost izvajanju teh politik, da se zagotovi hitro in učinkovito prilagajanje podnebnim spremembam;
1). ) can help to address this issue in Europe; calls on the Commission and Member States to attach the highest priority to implementation of these policies, so as to ensure rapid and efficient adaptation to climate change;
pozdravlja pobudo Komisije, da ustanovi evropsko svetovalno skupino za prilagajanje podnebnim spremembam, in poudarja, da mora ta strokovna skupina zagotoviti zmogljivosti za izvajanje usklajenih medsedktorskih strategij na ravni EU in za okvire politik, ki bi lahko zagotovile pobude za vlaganja v dejavnosti prilagajanja podnebnim spremembam in njihove blažitve;
Welcomes the Commission’s initiative to establish a European Advisory Group for Adaptation to Climate Change and stresses the need for this expert group to provide capabilities for realising coherent intersectoral strategies at EU level as well as for enhancing policy frameworks that could provide incentives for investing in climate change adaptation and mitigation activities;
naroči svojemu predsedniku, naj to resolucijo posreduje Komisiji kot prispevek Parlamenta k posvetovanju zainteresiranih strani o zeleni knjigi, ki jo je predlagala Komisija.
Instructs its President to forward this resolution to the Commission as Parliament’s contribution to the stakeholder consultation process on the Green Paper initiated by the Commission.
k vprašanju za ustni odgovor B6‑0000/2007
further to Question for Oral Answer B6‑0000/2007
ki ga predlagajo Miroslav Ouzký, Antonios Trakatellis, Glenis Willmott, Georgs Andrejevs, Caroline Lucas, Adamos Adamou, Liam Aylward, Kathy Sinnott in Irena Belohorská
by Miroslav Ouzký, Antonios Trakatellis, Glenis Willmott, Georgs Andrejevs, Caroline Lucas, Adamos Adamou, Liam Aylward, Kathy Sinnott and Irena Belohorská
o boju proti raku v razširjeni Evropski uniji
on combating cancer in the enlarged European Union
Resolucija Evropskega parlamenta o boju proti raku v razširjeni Evropski uniji
European Parliament resolution on combating cancer in the enlarged European Union
ob upoštevanju člena 152 Pogodbe o ES,
having regard to Article 152 of the Treaty,
ob upoštevanju členov 163 do 173 Pogodbe o ES,
having regard to Articles 163-173 of the Treaty,
ob upoštevanju drugega programa ukrepov Skupnosti na področju zdravja (2008-2013) UL L 301, 20.11.2007. ,
having regard to the Second Programme of Community Action in the Field of Health 2008-2013, OJ L 301, 20.11.2007.
ob upoštevanju bele knjige Komisije z naslovom Skupaj za zdravje: strateški pristop EU za obdobje 2008–2013 KOM(2007) 630 končno. ,
having regard to the Commission’s White Paper ‘Together for Health: A Strategic Approach for the EU 2008-2013’, COM (2007) 630 final.
ob upoštevanju sedmega okvirnega programa Evropske skupnosti za raziskave, tehnološki razvoj in predstavitvene dejavnosti (2007-2013) UL L 412, 30.12.2006. ,
having regard to the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007-2013), OJ L 412, 30.12.2006.
ob upoštevanju Direktive 2004/37/ES Evropskega parlamenta in Sveta z dne 29. aprila 2004 o varovanju delavcev pred nevarnostmi zaradi izpostavljenosti rakotvornim ali mutagenim snovem pri delu, UL L 158, 30.4.2004, str.
having regard to Directive 2004/37/EC of the European Parliament and of the Council of 29 April 2004 on the protection of workers from the risks related to exposure to carcinogens or mutagens at work, OJ L 158, 30.4.2004, p.
ob upoštevanju poročil Svetovne zdravstvene organizacije o boju proti raku, še zlasti o zdravstvenih tveganjih za otroke zaradi izpostavljenosti kemikalijam Načela za ocenjevanje zdravstvenih tveganj pri otrocih, Svetovna zdravstvena organizacija, 2006. ,
having regard to reports commissioned by the World Health Organisation on cancer, and in particular on health risks for children due to exposure to chemicals, Principles for Evaluating Health Risks in Children, WHO, 2006.
ob upoštevanju Uredbe (ES) št. 1901/2006 o zdravilih za pediatrično uporabo UL L 378, 27.12.2006. ,
having regard to Regulation (EC) No 1901/2006 on medicinal products for paediatric use, OJ L 378, 27.12.2006.
ob upoštevanju priporočila Sveta z dne 2. decembra 2003 o preventivnih pregledih v zvezi z rakom UL L 327, 16.12.2003. ,
having regard to the Council Recommendation of 2 December 2003 on cancer screening, OJ L 327, 16.12.2003.
ob upoštevanju sporočila Komisije o evropski strategiji za okolje in zdravje ter sporočila Komisije o evropskemu akcijskemu načrtu za okolje in zdravje 2004-2010 KOM(2003) 338 končno in KOM(2004) 416 končno. ,
having regard to the Commission Communication on a European Environment and Health Strategy and the Commission Communication on European Environment & Health Action Plan 2004-2010, COM(2003) 338 final and COM(2004) 416 final.
ob upoštevanju svoje pisne izjave o potrebi po celostni strategiji za nadzor rakavih obolenj, sprejete dne 27. septembra 2007 Pisna izjava št. 0052/2007. ,
having regard to its Written Declaration on the need for a comprehensive strategy to control cancer, adopted on 27 September 2007, WD 0052/2007.
ob upoštevanju akcijskega načrta Skupnosti proti raku UL L 95, 16.4.1996. ,
having regard to the Community action plan against cancer, OJ L 95, 16.04.1996.
ob upoštevanju člena 88a Direktive 2001/83/ES, kakor je bila spremenjena z Direktivo 2004/27/ES o zakoniku Skupnosti o zdravilih za uporabo v humani medicini UL L 136, 30.4.2004. ,
having regard to Article 88a of Directive 2001/83/EC, as amended by Directive 2004/27/EC, on the Community code relating to medicinal products for human use, OJ L 136, 30.04.2004.
ob upoštevanju sklepa Sveta z dne 2. junija 2004 o sklenitvi okvirne konvencije Svetovne zdravstvene organizacije o nadzoru tobaka UL L 213, 15.6.2004. ,
having regard to the Council Decision of 2 June 2004 concerning the conclusion of the WHO Framework Convention on Tobacco Control, OJ L 213, 15.06.2004.
ker po ocenah Mednarodne agencije za raziskave raka vsak tretji Evropejec zboli za rakom, vsaki četrti pa zaradi te bolezni umre,
whereas, according to estimates by the International Agency for Research on Cancer (IARC), one in three Europeans is diagnosed with cancer during their lifetime and one in four Europeans dies from the disease,
ker je bilo v letu 2006 v EU odkritih skoraj 2,3 milijona novih primerov raka, več kot milijon ljudi pa je zaradi njega umrlo; ker je bila večina smrtnih primerov pri osebah z rakom na pljučih, debelem črevesu in dojkah,
whereas in 2006 there were nearly 2.3 million new cancer cases and over 1 million cancer deaths within the EU; whereas most deaths were in people with lung cancer, colorectal cancer and breast cancer,
ker raka povzročajo številni dejavniki na več stopnjah, zato je potrebna nova paradigma za preprečevanje raka, ki bo v enaki meri obravnavala vzroke, povezane z načinom življenja, ter poklicne in okoljske vzroke,
whereas cancer is caused by many factors in multiple stages and therefore requires a new cancer prevention paradigm that addresses lifestyle causes and occupational and environmental causes on an equal footing,
ker je po nedavnih raziskavah sindikatov izpostavljenost rakotvornim snovem na delovnem mestu neposreden vzrok za najmanj 8 % smrtnih primerov zaradi raka vsako leto; ker bi lahko tako izpostavljenost preprečili z nadomestitvijo rakotvornih snovi z manj škodljivimi; ker so delodajalci resda pravno zavezani, da nadomestijo rakotvorne snovi, kjer je to mogoče, a se te določbe na žalost premalo upoštevajo in izvajajo, kar pa ni sprejemljivo,
whereas, according to a recent study by the trade unions, at least 8% of annual cancer deaths are directly caused by exposure to carcinogens at the workplace; whereas such exposure could be prevented by substitution of carcinogens with less harmful substances; whereas employers are indeed legally obliged to substitute carcinogens where possible but, unfortunately, these provisions are poorly implemented and enforced, which is not acceptable,
ker je eden izmed razlogov za povečanje števila primerov rakavih obolenj staranje populacije v Uniji,
whereas the Union’s ageing population is one of the reasons for the increase in the cancer burden across the Union,
ker je delež smrtnih primerov zaradi raka v novih državah članicah višji kot v EU-15,
whereas death rates from cancer in the new Member States are higher than in the EU‑15,
ker so osupljive in nesprejemljive razlike v kakovosti ustanov za zdravljenje raka, programih preventivnih pregledov, smernicah za najboljšo prakso, ki temeljijo na dokazih, ustanovah za radioterapijo in v dostopnosti zdravil proti raku med razlogi za velike razlike v petletni stopnji preživetja z večino rakavih obolenjih v Evropi,
whereas the startling and unacceptable differences in the quality of cancer treatment facilities, screening programmes, evidence-based best-practice guidelines, facilities for radiotherapy, and access to anti-cancer drugs are among the reasons for the big differences in the five-year survival rate from most cancers across Europe,
ker Evropski parlament v pisni izjavi o potrebi po celostni strategiji za nadzor rakavih obolenj poziva Svet in Komisijo, naj oblikujeta celostno strategijo za nadzor rakavih obolenj, ki bo zajemala štiri glavne dejavnike za nadzor rakavih obolenj: preventivo, zgodnje odkrivanje, diagnosticiranje, zdravljenje in nadaljnje spremljanje ter paliativno oskrbo,
whereas the European Parliament’s Written Declaration on the need for a comprehensive strategy to control cancer calls on the Council and Commission to formulate a comprehensive cancer control strategy addressing the four basic cancer control factors: prevention, early detection, diagnosis, treatment and follow-up, and palliative care,
ker je v obdobju akcijskega načrta Komisije proti raku (Evropa proti raku 1986–2002) v številnih državah prišlo do ugodnih trendov v zvezi z umrljivostjo zaradi raka pri več pogostih oblikah raka,
whereas during the term of the Commission’s Action Plans Against Cancer (‘Europe against cancer’ 1986-2002) favourable trends in cancer mortality were established for several common forms of cancer in many countries,
ker Svetovna zdravstvena organizacija ocenjuje, da je tretjino vseh primerov raka mogoče preprečiti in da je preventiva stroškovno najučinkovitejša dolgoročna strategija za nadzor raka; ker bi bilo dodatno tretjino primerov raka mogoče ozdraviti, če bi bili odkriti v zgodnji fazi in primerno zdravljeni,
whereas the WHO estimates that at least one third of all cancer cases are preventable and that prevention offers the most cost-effective long-term strategy for the control of cancer; whereas another third of cancers could be cured if detected early and treated appropriately,
ker je Svetovna zdravstvena organizacija uvrstila kristalni kremen med rakotvorne snovi prvega razreda in ker je 3,2 milijona delavcev v EU izpostavljenih tej snovi vsaj 75 % njihovega delovnega časa; ker se ocenjuje, da je 2,7 % smrti zaradi pljučnega/bronhialnega raka mogoče pripisati poklicni izpostavljenosti kristalnemu kremenu,
whereas crystalline silica has been classified by the WHO as a class 1 carcinogen and whereas 3.2 million workers in the EU are exposed to this substance during at least 75% of their working time; whereas 2.7% of deaths due to lung/bronchial cancers are estimated to be attributable to occupational exposure to crystalline silica,
ker po podatkih Organizacije za gospodarsko sodelovanje in razvoj njene članice zdaj porabijo v povprečju samo 3 % svojega celotnega zdravstvenega proračuna za preventivo, 97 % pa za zdravstvene storitve in zdravljenje ; ker je treba to ogromno neravnotežje nujno popraviti, še toliko bolj, ker je mogoče preprečiti vsaj tretjino vseh primerov rakavih obolenj,
whereas, according to OECD data, currently only an average 3% of the OECD countries’ total budget for health is spent on prevention as against 97% spent on healthcare and treatment; whereas this gross imbalance needs to be urgently rectified, all the more so as at least one third of all cancer cases are preventable,
ker se ocenjuje, da je kajenje vzrok za 25 % vseh smrtnih primerov zaradi raka v Evropski uniji; ker kajenje povzroči 80 do 90 % smrtnih primerov zaradi pljučnega raka po svetu,
whereas it is estimated that 25% of all cancer deaths in the European Union can be attributed to smoking; whereas smoking causes between 80 and 90% of lung cancer deaths worldwide,
ker lahko dobro zasnovan nacionalni program za nadzor raka, s katerim se dobro upravlja, zmanjša pogostost in smrtnost rakavih obolenj – v nekaterih primerih tudi za več kot 70 % – ter izboljša življenje obolelih za rakom, ne glede na to, kako omejena so sredstva držav,
whereas a well-designed, well-managed national cancer control programme lowers cancer incidence and mortality, in some cases by more than 70%, and improves the life of cancer patients, no matter what resource constraints a country faces,
ker izvajanje učinkovitih programov za zgodnje odkrivanje, ki temeljijo na prebivalstvu in se izvajajo na ravni držav (in v skladu z evropskimi smernicami, če že obstajajo), močno izboljša kakovost in dostopnost zgodnjega odkrivanja raka, diagnostike in terapevtskega zdravljenja za prebivalstvo ter s tem tudi izboljša nadzor raka,
whereas nationwide implementation of effective, population-based screening programmes – run in accordance with European guidelines if they already exist – significantly improves the quality and accessibility of cancer screening, diagnosis and therapeutic services to the population and thereby also improves cancer control,
ker so nacionalni registri za primere raka v vseh državah članicah EU bistveni za zagotavljanje primerljivih podatkov o rakavih obolenjih,
whereas national cancer registries in all EU Member States are essential with a view to providing comparable data on cancer,
ker zdaj v EU obstajajo velike in nesprejemljive razlike v kakovosti preventivnih pregledov za rakava obolenja ter zgodnjega odkrivanja in spremljanja, zlasti kar zadeva uporabljene diagnostične postopke in vključevanje teh postopkov v zdravstveno politiko držav članic; ker preventivni pregledi olajšajo zgodnje diagnosticiranje, kar prispeva k stroškovno učinkovitemu in merljivemu zmanjšanju števila primerov rakavih obolenj,
whereas there are currently considerable, and unacceptable, qualitative inequalities in cancer screening and early detection and follow-up within the EU, particularly with regard to the diagnostic procedures used and the integration of those procedures into Member States’ health policy, and whereas screening programmes facilitate early diagnosis, which contributes to a cost-effective and measurable reduction in disease burden,
ker se onkologija v vseh državah članicah EU ne priznava kot zdravniška specializacija in ker je treba zagotavljati nenehno zdravstveno izobraževanje,
whereas oncology is not recognised as a medical speciality in all EU Member States, and whereas continuing medical education needs to be provided,
ker evropska podatkovna baza Evropske agencije za zdravila za klinično preizkušanje (EudraCT) ni javno dostopna in pacienti težko najdejo preizkušanje, ki zadeva njihovo zdravstveno stanje,
whereas EudraCT, the European database for clinical trials at the EMEA, is not open to the general public, and patients have difficulty in locating trials that address their specific condition,
ker zapletenost rakavih obolenj zahteva boljšo komunikacijo med številnimi in raznovrstnimi zdravstvenimi strokovnjaki, ki sodelujejo pri zdravljenju obolelih z rakom; ker lahko psihosocialna oskrba obolelih z rakom izboljša kakovost njihovega življenja,
whereas the complexity of cancer requires improved communication between the many and varied healthcare professionals involved in cancer patient treatment; whereas psychosocial care of cancer patients can improve their quality of life,
ker oboleli z rakom zaenkrat nimajo enakopravnega dostopa do zdravstvenih podatkov in na vsaki stopnji svoje bolezni nujno potrebujejo več informacij,
whereas cancer patients currently have unequal access to medical information and are in urgent need of more information at every stage of their disease,
poziva Komisijo, Svet in države članice, naj sprejmejo ustrezne ukrepe za preprečevanje, zgodnje odkrivanje, diagnosticiranje in zdravljenje, vključno s paliativno oskrbo, da se zmanjša veliko povečanje bremena zaradi rakavih obolenj, ki se približuje zaradi demografskih sprememb v naslednjih desetletjih, tudi z zagotavljanjem ustrezne finančne podpore za usklajene ukrepe in primerno krepitev zmogljivosti;
Calls on the Commission, the Council and the Member States to take appropriate action on prevention, early detection, diagnosis and treatment, including palliative care, in order to reduce the significant approaching increase in the burden of cancer resulting from demographic changes in the coming decades, including provision of adequate financial support for coordinated actions and appropriate capacity building;
poziva Komisijo, naj oblikuje medinstitucionalno delovno skupino EU za boj proti raku, ki bi jo sestavljali predstavniki Komisije, Sveta in Evropskega parlamenta, ki bi se redno srečevali ter zbirali in izmenjevali zglede najboljše prakse za preprečevanje (vključno z zmanjševanjem poklicne in okoljske izpostavljenosti rakotvornim snovem), preventivne preglede in zdravljenje ter zagotavljali vodenje pri boljšem nadzoru nad rakom v Evropi; poudarja, da bi morala delovna skupina EU še zlasti spodbujati nove ukrepe, pa tudi obstoječe projekte za preventivne preglede, ki bi lahko pripomogli k povečanju deleža prebivalstva, ki sodeluje pri ukrepih preventivnih pregledov za rakava obolenja, za vsaj 50 % v vsaki državi članici do leta 2018;
Calls on the Commission to set up an interinstitutional EU Cancer Task Force made up of representatives from the Commission, the Council and the European Parliament, which would meet on a regular basis to collect and exchange best practice on prevention (including reducing occupational and environmental exposure to carcinogens), screening and treatment and to provide leadership in improved cancer control in Europe; stresses that the EU Task Force should, in particular, promote new measures, as well as existing screening projects, that could help increase the proportion of the population taking part in cancer screening measures by at least 50% in each of the Member States by 2018;
pozdravlja pobudo Komisije za sprejetje sporočila o raku in sporočila o redkih boleznih;
Welcomes the Commission’s initiative of adopting a Communication on Cancer and a Communication on Rare Diseases;
poziva Komisijo, naj redno pregleduje evropski kodeks proti raku in ga promovira v kampanjah za ozaveščanje, obveščanje in izobraževanje, namenjenih točno določenim skupinam prebivalstva;
Asks the Commission to review the European Code Against Cancer on a regular basis and to promote it by means of awareness, information and education campaigns targeting specific population groups;
poziva države članice, naj izvajajo obvezno beleženje primerov raka s standardizirano evropsko terminologijo, da se zagotovi zmogljivosti, s katerimi se na podlagi prebivalstva ocenjuje programe preventive, zgodnje diagnostike in zdravljenja, stopnje preživetja in primerljivost podatkov med državami članicami;
Urges the Member States to implement statutory cancer registration with European standardised terminology in order to provide the capacity for population-based evaluation of prevention, screening and treatment programmes, survival rates and comparability of data between Member States;
poziva Komisijo, naj revidira sedanje priporočilo o preventivnih pregledih za rakava obolenja, da bo upoštevalo hiter razvoj novih tehnologij in zajelo:
Calls on the Commission to revise the existing Recommendation on Cancer Screening to take account of the rapid development of new technologies and to include:
(a) več vrst rakavih obolenj in
(a) more types of cancers and
(b) dodatne tehnike zgodnjega odkrivanja, ko so te znanstveno preverjene;
(b) additional techniques of early diagnosis when these are warranted scientifically;
poziva Komisijo, naj oblikuje dinamičen, prožen in stalen pristop za boj proti raku, ki bo temeljil na znanstvenem napredku, ter v ta namen ustanovi:
Calls on the Commission to establish a dynamic, flexible, continuous approach to fighting cancer that is based on scientific progress, and to this end to establish:
(a) svetovalni odbor za preprečevanje raka, ki bo ocenil sedanje dokaze in podatke;
(a) an advisory committee on cancer prevention to evaluate existing evidence and data;
(b) poseben svetovalni odbor za zgodnje odkrivanje raka, da zagotovi hitro in učinkovito vključevanje prihodnjih revizij priporočila;
(b) a special advisory committee on early detection of cancer to ensure that future revisions of the recommendation are incorporated rapidly and efficiently;
poziva Komisijo, naj v okviru drugega akcijskega programa za javno zdravje podpre omrežja nacionalnih registrov za primere raka, da bi se izvedla študija za celo EU o razlikah v pojavljanju in preživetju rakavih obolenj;
Calls on the Commission to support, within the framework of the Second Public Health Action Programme, networks of national cancer registries with a view to carrying out an EU‑wide study of inequalities in cancer incidence and survival;
poziva vladi Češke in Italije, ki še nista ratificirali okvirne konvencije o nadzoru tobaka, ki je začela veljati februarja 2005, naj to storita;
Urges the Governments of the Czech Republic and Italy, which have not yet done so, to ratify the Framework Convention on Tobacco Control, which entered into force in February 2005;
poziva Komisijo in vse države članice EU, naj pri izvajanju okvirne konvencije o nadzoru nad tobakom razvijejo in podpirajo trdne protokole in smernice ter zagotovijo, da bodo na voljo sredstva, ki bodo državam z nizkimi dohodki pomagala pri izpolnjevanju njihovih obveznosti v skladu s to konvencijo;
Calls on the Commission and all EU Member States to develop and support strong protocols and guidelines when implementing the Framework Convention on Tobacco Control and to ensure that resources are available to help low-income countries to meet their obligations under the Convention;
poziva Komisijo, naj kot varuhinja pogodbe takoj sprejme pravne ukrepe proti vsem državam članicam, ki ne izvajajo v celoti Direktive 2004/37/ES o varovanju delavcev pred nevarnostmi zaradi izpostavljenosti rakotvornim ali mutagenim snovem pri delu;
Calls on the Commission to act in its role as guardian of the Treaty by taking swift legal action against all Member States that are not fully implementing Directive 2004/37/EC on the protection of workers from the risks related to exposure to carcinogens or mutagens at work;
poziva Komisijo, naj po potrebi sprejme zakonodajo ter spodbuja in podpira pobude, ki vključujejo širok spekter zainteresiranih strani, da bi preprečevali rakava obolenja z zmanjšanjem poklicne in okoljske izpostavljenosti rakotvornim snovem ter s spodbujanjem zdravega načina življenja – zlasti kar zadeva glavne dejavnike tveganja, kot so tobak, alkohol, prekomerna telesna teža, nezdravi načini prehranjevanja ter premajhna telesna dejavnost in slaba zaščita pred soncem – in z močnim poudarkom na otrocih in najstnikih;
Calls on the Commission to take legislative action where appropriate and to encourage and support initiatives that include a wide range of stakeholders with the aim of preventing cancer by reducing occupational and environmental exposure to carcinogens and promoting healthy lifestyles, in particular as regards the major risk factors – tobacco, alcohol, obesity, unhealthy diets, and lack of physical activity and sun protection –, with strong emphasis on children and adolescents;